Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Transformation of double-hit follicular lymphoma to plasmablastic lymphoma: a partial role of MYC gene rearrangement.

Ise M, Kageyama H, Ikebe D, Araki A, Kumagai K, Itami M.

J Clin Exp Hematop. 2018 Sep 19;58(3):128-135. doi: 10.3960/jslrt.18003. Epub 2018 Jul 14.

2.

Magnified endoscopic observation of small depressed gastric lesions using linked color imaging with indigo carmine dye.

Kitagawa Y, Hara T, Ikebe D, Nankinzan R, Takashiro H, Kobayashi R, Nakamura K, Yamaguchi T, Suzuki T.

Endoscopy. 2018 Feb;50(2):142-147. doi: 10.1055/s-0043-119212. Epub 2017 Sep 27.

PMID:
28954304
3.

Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm.

Ono K, Ise M, Ikebe D, Sato A, Wang X, Sugawara T, Tsujimura H, Itami M, Kumagai K.

Rinsho Ketsueki. 2017;58(2):150-154. doi: 10.11406/rinketsu.58.150. Japanese.

PMID:
28321093
4.

Frequent Presence of Lymphovascular Invasion in Small Rectal Neuroendocrine Tumors on Immunohistochemical Analysis.

Kitagawa Y, Ikebe D, Suzuki T, Hara T, Itami M, Yamaguchi T.

Digestion. 2017;95(1):16-21. doi: 10.1159/000452357. Epub 2017 Jan 5. Review.

5.

Enhanced detection of lymphovascular invasion in small rectal neuroendocrine tumors using D2-40 and Elastica van Gieson immunohistochemical analysis.

Kitagawa Y, Ikebe D, Hara T, Kato K, Komatsu T, Kondo F, Azemoto R, Komoda F, Tanaka T, Saito H, Itami M, Yamaguchi T, Suzuki T.

Cancer Med. 2016 Nov;5(11):3121-3127. doi: 10.1002/cam4.935. Epub 2016 Oct 17.

6.

Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors.

Nakamura R, Yamamoto N, Shiina N, Miyaki T, Ikebe D, Itami M, Shida T, Miyazaki M.

Breast. 2016 Apr;26:141-7. doi: 10.1016/j.breast.2015.10.009. Epub 2015 Dec 28.

7.

Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation.

Tsujimura H, Miyaki T, Yamada S, Sugawara T, Ise M, Iwata S, Yonemoto T, Ikebe D, Itami M, Kumagai K.

Int J Hematol. 2014 Nov;100(5):507-10. doi: 10.1007/s12185-014-1630-y. Epub 2014 Jul 26.

PMID:
25062797
8.

Impact of infiltrative growth on the outcome of patients with undifferentiated pleomorphic sarcoma and myxofibrosarcoma.

Iwata S, Yonemoto T, Araki A, Ikebe D, Kamoda H, Hagiwara Y, Ishii T.

J Surg Oncol. 2014 Nov;110(6):707-11. doi: 10.1002/jso.23708. Epub 2014 Jun 29.

PMID:
24975462
9.

Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice.

Yokoyama S, Kitamoto S, Higashi M, Goto Y, Hara T, Ikebe D, Yamaguchi T, Arisaka Y, Niihara T, Nishimata H, Tanaka S, Takaori K, Batra SK, Yonezawa S.

PLoS One. 2014 Apr 8;9(4):e93760. doi: 10.1371/journal.pone.0093760. eCollection 2014.

10.

Pulmonary artery sarcoma diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.

Shingyoji M, Ikebe D, Itakura M, Nakajima T, Itami M, Kimura H, Iizasa T.

Ann Thorac Surg. 2013 Aug;96(2):e33-5. doi: 10.1016/j.athoracsur.2013.01.080.

PMID:
23910141
11.

Preoperative histological subtype classification of intraductal papillary mucinous neoplasms (IPMN) by pancreatic juice cytology with MUC stain.

Hara T, Ikebe D, Odaka A, Sudo K, Nakamura K, Yamamoto H, Itami M, Hirata T, Kashimura J, Yamaguchi T.

Ann Surg. 2013 Jun;257(6):1103-11. doi: 10.1097/SLA.0b013e318281b824.

PMID:
23364699
12.

ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity.

Kimura H, Nakajima T, Takeuchi K, Soda M, Mano H, Iizasa T, Matsui Y, Yoshino M, Shingyoji M, Itakura M, Itami M, Ikebe D, Yokoi S, Kageyama H, Ohira M, Nakagawara A.

Lung Cancer. 2012 Jan;75(1):66-72. doi: 10.1016/j.lungcan.2011.05.027. Epub 2011 Jul 14.

PMID:
21757253
13.

Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch.

Muto A, Ochiai K, Kimura Y, Itoh-Nakadai A, Calame KL, Ikebe D, Tashiro S, Igarashi K.

EMBO J. 2010 Dec 1;29(23):4048-61. doi: 10.1038/emboj.2010.257. Epub 2010 Oct 15.

14.

EML4-ALK fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration.

Sakairi Y, Nakajima T, Yasufuku K, Ikebe D, Kageyama H, Soda M, Takeuchi K, Itami M, Iizasa T, Yoshino I, Mano H, Kimura H.

Clin Cancer Res. 2010 Oct 15;16(20):4938-45. doi: 10.1158/1078-0432.CCR-10-0099. Epub 2010 Oct 5.

15.

Overexpression of the transcription factor Yin-Yang-1 suppresses differentiation of HaCaT cells in three-dimensional cell culture.

Taguchi S, Kawachi Y, Ishitsuka Y, Fujisawa Y, Furuta J, Nakamura Y, Xu X, Ikebe D, Kato M, Otsuka F.

J Invest Dermatol. 2011 Jan;131(1):37-45. doi: 10.1038/jid.2010.229. Epub 2010 Aug 5.

16.
17.

Nuclear positioning of the BACH2 gene in BCR-ABL positive leukemic cells.

Ono A, Kono K, Ikebe D, Muto A, Sun J, Kobayashi M, Ueda K, Melo JV, Igarashi K, Tashiro S.

Genes Chromosomes Cancer. 2007 Jan;46(1):67-74.

PMID:
17044046
18.

Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1.

Yoshida C, Yoshida F, Sears DE, Hart SM, Ikebe D, Muto A, Basu S, Igarashi K, Melo JV.

Blood. 2007 Feb 1;109(3):1211-9. Epub 2006 Oct 3.

PMID:
17018862
19.

Synchronous unilateral parotid gland neoplasms of three different histological types.

Tanaka S, Tabuchi K, Oikawa K, Kohanawa R, Okubo H, Ikebe D, Noguchi M, Hara A.

Auris Nasus Larynx. 2007 Jun;34(2):263-6. Epub 2006 Aug 30.

PMID:
16938417
20.

The transcriptional programme of antibody class switching involves the repressor Bach2.

Muto A, Tashiro S, Nakajima O, Hoshino H, Takahashi S, Sakoda E, Ikebe D, Yamamoto M, Igarashi K.

Nature. 2004 Jun 3;429(6991):566-71. Epub 2004 May 19.

21.

B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs.

Kamio T, Toki T, Kanezaki R, Sasaki S, Tandai S, Terui K, Ikebe D, Igarashi K, Ito E.

Blood. 2003 Nov 1;102(9):3317-22. Epub 2003 Jun 26.

PMID:
12829606

Supplemental Content

Support Center